3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Neuroblastoma
44
Brain Neoplasms
18
Central Nervous System Neoplasms
12
Glioma
11
Medulloblastoma
8
Neoplasms
6
Gliosarcoma
6
Glioblastoma
6
Ganglioneuroblastoma
6
Astrocytoma
6
Sarcoma, Ewing
5
Sarcoma
5
Rhabdomyosarcoma
5
Rhabdoid Tumor
5
Recurrence
5
Meningeal Carcinomatosis
5
Wilms Tumor
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Oligodendroglioma
3
Lymphoma
3
Familial ependymoma
3
Dendritic Cell Sarcoma, Interdigitating
3
Burkitt Lymphoma
3
Testicular Neoplasms
2
Retinoblastoma
2
Ovarian Neoplasms
2
Osteosarcoma
2
Optic Nerve Glioma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neoplasm Metastasis
2
Interventions
Sirolimus
3
Melphalan
3
Granulocyte Colony-Stimulating Factor
3
Cyclophosphamide
3
Automobiles
3
pembrolizumab
2
fludarabine
2
etoposide phosphate
2
Stem Cell Transplantation
2
Mesna
2
Immunotherapy
2
Gemcitabine
2
Etoposide
2
Carboplatin
2
Busulfan
2
vorasidenib
1
trametinib
1
tozuleristide
1
sonidegib
1
sodium thiosulfate
1
ripretinib
1
ribociclib
1
pegylated granulocyte colony-stimulating factor
1
lutetium Lu 177 dotatate
1
interferon gamma-1b
1
fludarabine phosphate
1
Watchful Waiting
1
Vorinostat
1
Ursodeoxycholic Acid
1
Topotecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms, Germ Cell and Embryonal
×
Topotecan
×
CNS
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled